Drug Shortage Report for TARO-QUETIAPINE
Report ID | 61831 |
Drug Identification Number | 02397129 |
Brand name | RAN-QUETIAPINE |
Common or Proper name | RAN-QUETIAPINE |
Company Name | SUN PHARMA CANADA INC |
Market Status | DORMANT |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-09-14 |
Actual start date | |
Estimated end date | |
Actual end date | 2018-09-13 |
Shortage status | Avoided shortage |
Updated date | 2019-02-15 |
Company comments | duplicate entry |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v12 | 2019-02-15 | French | Compare |
v11 | 2019-02-15 | English | Compare |
v10 | 2019-02-11 | French | Compare |
v9 | 2019-02-11 | English | Compare |
v8 | 2019-02-04 | French | Compare |
v7 | 2019-02-04 | English | Compare |
v6 | 2019-01-17 | French | Compare |
v5 | 2019-01-17 | English | Compare |
v4 | 2018-11-28 | French | Compare |
v3 | 2018-11-28 | English | Compare |
v2 | 2018-09-18 | French | Compare |
v1 | 2018-09-18 | English | Compare |
Showing 1 to 12 of 12